CBS2025
CBS 2025 will focus on the cutting-edge academic content including Intervention for Complex Coronary Lesions, Pulmonary Hypertension, Heart Failure, Basic and Clinical Research Training.
| Results： | ||||||
|
Date/Time |
Room |
Session |
Name |
Role |
Presentation Title |
|
|---|---|---|---|---|---|---|
| 8:30 am-9:50 am |
|
Duanmin Xu | Discussant | |||
| 8:30 am-9:50 am |
|
Shihua Zhao | Discussant | |||
| 8:30 am-10:00 am |
|
Linzhang Huang | Discussant | |||
| 8:30 am-8:45 am |
|
Jieyan Shen | Speaker | Application of Multimodality Technology in Pulmonary Hypertension Diagnosis | ||
| 8:30 am-8:40 am |
|
Shao-Liang Chen | Host | Opening Remarks | ||
| 8:40 am-8:55 am |
|
Yong Ji | Speaker | Novel Therapeutic Targets for Vascular Remodeling Disease | ||
| 8:50 am-9:05 am |
|
Zaixin Yu | Speaker | Determinants of the Dimension of Pulmonary Artery in Patients With PAH | ||
| 9:00 am-9:15 am |
|
Qi Chen | Speaker | Regulation of Inflammation in Vascular Remodeling | ||
| 9:10 am-9:25 am |
|
Qin Luo | Speaker | Prognosis and Clinical Characteristics of Mild PAH under the Updated Hemodynamic Criteria | ||
| 9:20 am-9:35 am |
|
Jun Pu | Speaker | Obesity and Organ Damage: Insights from a Large-Scale Cohort Study | ||
| 9:30 am-9:45 am |
|
Bo Wu | Speaker | Hot Issues in Lung Transplantation for Pulmonary Arterial Hypertension | ||
| 9:40 am-9:55 am |
|
Alex F Chen | Speaker | Vascular Endothelial Injury in Diabetes | ||
| 10:00 am-11:20 am |
|
Tingbo Jiang | Moderator | |||
| 10:00 am-12:00 pm |
|
Chaoqun Zhang | Moderator | |||
| 10:00 am-12:00 pm |
|
Cao Zou | Moderator | |||
| 10:00 am-11:20 am |
|
Jieyan Shen | Moderator | |||
| 10:00 am-12:00 pm |
|
Qiqiang Jie | Discussant | |||
| 10:00 am-11:20 am |
|
Shubo Song | Discussant | |||
| 10:00 am-11:20 am |
|
Qiangqiang Li | Discussant | |||
| 10:00 am-11:20 am |
|
Esmond Yan Hang Fong | Discussant | |||
| Records:1107 Pre[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Next | ||||||
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
